Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity

Journal of Peptide Science

Volumn 14, Issue 4, 2008, Pages 482-487

  Henriques, Sónia Troeira ^a   Castanho, Miguel A R B ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

Anti microbial peptides; Cell penetrating peptides; Drug delivery; Peptide membrane interactions; Translocation mechanism

Indexed keywords

BETA GALACTOSIDASE; CELL PENETRATING PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN PEP 1; THIOREDOXIN; UNCLASSIFIED DRUG; VALINOMYCIN;

ANTIMICROBIAL ACTIVITY; BINDING KINETICS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; FLUORESCENCE ANALYSIS; HUMAN; IN VITRO STUDY; INTERNALIZATION; LIPID MEMBRANE; MEMBRANE POTENTIAL; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW;

CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CYSTEAMINE; ENDOCYTOSIS; HELA CELLS; HUMANS; PEPTIDES; PROTEIN TRANSPORT;

EID: 42149177168     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1003     Document Type: Review

References (40)

1. Wadia JS, Becker-Hapak M, Dowdy SF. Protein transport. In Cell-Penetrating Peptides, Processes and Applications, Langel U (ed.). CRC Press: New York, 2002; 365-375.
2. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988; 55: 1189-1193.
3. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 1991; 88: 1864-1868.
4. Lindgren M, Hallbrink M, Prochiantz A, Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 2000; 21: 99-103.
5. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D: Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 10699-10704.
6. Fawell S, Seery J. Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. US.A. 1994; 91: 664-668.
7. Rojas M, Donahue JP, Tan Z, Lin YZ. Genetic engineering of proteins with cell membrane permeability. Nat. Biotechnol. 1998: 16: 370-375.
8. Rojas M, Yao S, Donahue JP, Lin YZ. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain. Biochem. Biophys. Res. Commun. 1997; 234: 675-680.
9. Theodore L, Derossi D, Chassaing G, Llirbat B, Kubes M, Jordan P, Chneiweiss H, Godement P, Prochiantz A. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J. Neurosci. 1995; 15: 7158-7167.
10. Allinquant B, Hantraye P, Mailleux P, Moya K, Bouillot C, Prochiantz A. Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J. Cell Biol. 1995; 128: 919-927.
11. Morris MC, Vidal P, Chaloin L, Heitz F, Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 1997; 25: 2730-2736.
12. Pooga M, Soomets U, Hallbrink M, Valkna A, Saar K, Rezaei K, Kahl U, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Hokfelt T, Bartfai T, Langel U. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 1998: 16: 857-861.
13. Henriques ST, Costa J, Castanho MA. Translocation of beta-galactosidase mediated by the cell-penetrating peptide pep-1 into lipid vesicles and human HeLa cells is driven by membrane electrostatic potential. Biochemistry 2005; 44: 10189-10198.
14. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000; 18: 410-414.
15. Torchilin VP, Rammohan R, Weissig V, Levchenko TS. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U.S.A. 2001; 98: 8786-8791.
16. Magzoub M, Graslund A. Cell-penetrating peptides: from inception to application. Q. Rev. Biophys. 2004; 37: 147-195.
17. Console S. Marty C, Garcia-Echeverria C, Schwendener R, Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 2003; 278: 35109-35114.
18. Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. Studies on the internalization mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 2003; 278: 31192-31201.
19. Fittipaldi A, Ferrari A, Zoppe M, Arcangeli C, Pellegrini V, Beltram F, Giacca M. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J. Biol. Chem. 2003; 278: 34141-34149.
20. Lundberg M, Wikstrom S, Johansson M. Cell surface adherence and endocytosis of protein transduction domains. Mol. Ther. 2003; 8: 143-150.
21. Potocky TB, Menon AK, Gellman SH. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 2003; 278: 50188-50194.
22. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 2003; 278: 585-590.
23. Thoren PE, Persson D, Isakson P, Goksor M, Onfelt A, Norden B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 2003; 307: 100-107.
24. Magzoub M, Pramanik A, Graslund A. Modeling the endosomal escape of cell-penetrating peptides: transmembrane pH gradient driven translocation. across phospholipid bilayers. Biochemistry 2005; 44: 14890-14897.
25. Terrone D, Sang SL, Roudaia L, Silvius JR. Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochemistry 2003; 42: 13787-13799.
26. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 2001; 19: 1173-1176.
27. Coulpier M, Anders J, Ibanez CF. Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival. J. Biol. Chem. 2002; 277: 1991-1999.
28. Ikari A, Nakano M, Kawano K, Suketa Y. Up-regulation of sodium-dependent glucose transporter by interaction with heat shock protein 70. J. Biol. Chem. 2002; 277: 33338-33343.
29. Zhou J, Hsieh JT. The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2. J. Biol. Chem. 2001; 276: 27793-27798.
30. Wu Y, Wood MD, Tao Y, Katagiri F. Direct delivery of bacterial avirulence proteins into resistant Arabidopsis protoplasts leads to hypersensitive cell death. Plant J. 2003; 33: 131-137.
31. Santos NC, Prieto M, Castanho MA, Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods. Biochim. Biophys. Acta 2003; 1612: 123-135.
32. Henriques ST, Castanho MA. Environmental factors that enhance the action of the cell penetrating peptide pep-1 A spectroscopic study using lipidic vesicles. Biochim. Biophys. Acta 2005; 1669: 75-86.
33. Sharonov A, Hochstrasser RM. Single-molecule imaging of the association of the Cell-penetrating peptide Pep-1 to model membranes. Biochemistry 2007; 46: 7963-7972.
34. Henriques ST, Castanho MA. Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. Biochemistry 2004; 43: 9716-9724.
35. Weller K, Lauber S, Lerch M, Renaud A, Merkle HP, Zerbe O. Biophysical and biological studies of end-group-modified derivatives of Pep-1. Biochemistry 2005: 44: 15799-15811.
36. Henriques ST, Quintas A, Bagatolli LA, Homble F, Castanho MA. Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1. Mol. Membr. Biol. 2007; 24: 282-293.
37. Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem. Biophys. Res. Commun. 2006; 349: 769-774.
38. Deshayes S, Heitz A, Morris MC, Charnet P, Divita G, Heitz F. Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. Biochemistry 2004; 43: 1449-1457.
39. Henriques ST, Costa J, Castanho MA. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence study using Pep-1. FEBS Lett. 2005; 579: 4498-4502.
40. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003; 55: 27-55.